A CD14 monocyte receptor polymorphism and genetic susceptibility to Parkinson's disease for females

Parkinsonism and Related Disorders

Volumn 12, Issue 1, 2006, Pages 9-13

  Lin, J J ^a   Chen, C H ^b   Yueh, K C ^a   Chang, C Y ^a   Lin, S Z ^c  

^a Chu Shang Show Chwan Hospital   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^c BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

Author keywords

Association study; CD 14 gene; Genetic polymorphism; Parkinson's disease; Risk factor

Indexed keywords

CD14 ANTIGEN;

ADULT; AGED; ALLELE; ARTICLE; CONTROLLED STUDY; EQUILIBRIUM CONSTANT; FEMALE; GENETIC ANALYSIS; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HOMOZYGOSITY; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; PARKINSON DISEASE; PATHOGENESIS; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SEX RATIO;

AGED; ANTIGENS, CD14; DNA; ETHNIC GROUPS; FEMALE; GENE FREQUENCY; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MONOCYTES; PARKINSON DISEASE; POLYMORPHISM, GENETIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RISK; SEX CHARACTERISTICS;

EID: 29844440184     PISSN: 13538020     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2005.07.010     Document Type: Article

References (36)

1. T. Foltynie, S. Sawcer, C. Brayne, and R.A. Barker The genetic basis of Parkinson's disease J Neurol Neurosurg Psychiatry 73 2000 363 370
2. J.R. Vaughan, M.B. Davis, and N.W. Wood Genetics of parkinsonism: a review Ann Hum Genet 65 2001 111 126
3. P.L. McGeer, K. Yasojima, and E.G. McGeer Inflammation in Parkinson's disease Adv Neurol 86 2001 83 89
4. P. Teismann, P. Tieu, O. Cohen, D.K. Choi, D.C. Wu, D. Marks, M Vila, V Jackson-Lewis, and S Przedborski Pathogenic role of glial cell in Parkinson's disease Mov Disord 18 2003 121 129
5. P.L. McGeer, S.S. Itagaki, B.E. Boyes, and E.G. McGeer Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's disease and Alzheimer's disease brains Neurology 38 1988 1285 1291
6. B. Liu, J.W. Jiang, B.C. Wilson, L. Du, SN Yang, JY Wang, GC Wu, XD Cao, and JS Hong Systemic infusion of naloxone reduces degeneration of rate substantia nigral dopaminergic neurons induced by intranigral injection of lipopolysaccharide J Pharmacol Expl Ther 295 2000 125 132
7. J.H. Bower, D.M. Maraganore, B.J. Peterson, J.E. Ahlskog, and W.A. Rocca Inflammatory and Parkinson's disease: A case-control study Mov Disord 19 Suppl. 9 2004 S192 S193
8. H. Chen, S.M. Zhang, M.A. Hermán, M.A. Schwarzschild, W.C. Willet, and G.A. Colditz Nonsteroidal anti-inflammatory drugs and the risk of Parkinson's disease Arch Neurol 60 2003 1059 1064
9. S.D. Wright, R.A. Ramos, P.S. Tobias, R.J. Ulevitch, and J.C. Mathison CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein Science 249 1990 1431 1433
10. M. Baldini, I.C. Lohman, M. Halonen, R.P. Erickson, P.G. Holt, and F.D. Martiznez A polymorphism in the 5′ flanking region of the CD14 gene is associated with circulating soluble CD14 levels and total serum immunoglobulin E Am J Respir Cell Mol Biol 20 1999 976 983
11. Eng HL, Chen CH, Kuo CC, Wu JS, Wang CH, Lin CH. Association of CD14 gene promoter polymorphism and Chlamydia pneumoniae infection. J Infect Dis 2003;188:90-96.
12. S.E. Daniel, and A.J. Lees Parkinson's disease Society Brain Bank London: overview and research. J Neurol Transm 39 1993 165 172
13. G.W. Ross, R.D. Abbott, H. Petroviteh, D.M. Morens, A.G. Grandinetti, K.H. Tung, CM Tanner, KH Masaki, PL Blanchette, JD Curb, JS Popper, and LR White Association of coffee and caffeine intake with the risk of Parkinson's disease J Am Med Assoc 283 2000 2674 2679
14. National High Blood Pressure Education Program. The seventh report of the joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7) Express. National Institutes of Health; 2003.
15. K. Unkelbach, A. Gardemann, M. Kostrewa, M. Philip, H. Tillmanns, and W.A. Haberbosch New promoter polymorphism in the gene of lipopolysaccharide receptor CD14 is associated with expired myocardial infarction in patients with low atherosclerotic risk profile Arterioscler Thromb Vasc Biol 19 1999 932 938
16. K.M. Mattila, J.O. Rinne, T. Lehtimäki, M. Röyttä, J.P. Ahonen, and M. Hurmer Association of an interleukin 1B gene polymorphism (-511) with Parkinson's disease in Finnish patients J Med Genet 39 2002 400 401
17. T. Schult, L. Schols, T. Muller, D. Woitalla, K. Berge, and R. Kruger Polymorphism in the interleulin-1 alpha and beta gene and the risk for Parkinson's disease Neurosci Lett 326 2002 70 72
18. M. Nishimura, I. Mizuta, E. Mizuta, S. Yamasaki, M. Ohta, R. Kaji, and S Kuno Tumor necrosis factor gene polymorphisms in patients with sporadic Parkinson's disease Neurosci Lett 311 2001 1 4
19. M. Yamamoto, I. Kondo, N. Ogawa, M. Asanuma, Y. Yamashita, and Y. Mizuno Genetic association between susceptibility to Parkinson's disease and α1-antichymotrypsin polymorphism Brain Res 759 1997 153 159
20. J.J. Lin, K.C. Yeuh, D.C. Chang, and S.Z. Lin Association between genetic polymorphism of angiotensin converting enzyme gene and Parkinson's disease J Neurol Sci 199 2002 25 29
21. R. Ross Atherosclerosis: an inflammatory disease N Engl J Med 340 1999 115 116
22. J.A. Hubacek, J. Pit'ha, Z. Skodova, V. Stanek, and R. Poledne C (-260)→T polymorphism in the promoter of the CD14 monocyte receptor gene as a risk factor for myocardial infarction Circulation 99 1999 3218 3220
23. D. Ito, M. Murata, N. Tanahashi, H. Sato, A. Sonoda, I. Saito, K Watanabe, and Y Fukvuchi Polymorphism in the promoter of lipopolysaccharide receptor CD14 and ischemic cerebrovascular disease Stroke 31 2000 2661 2664
24. K. Shimada, Y. Watanabe, H. Mokuno, Y. Iwama, H. Daida, and H. Yamaguchi Common polymorphism in the promoter of the CD14 monocyte receptor gene is associated with acute myocardial infarction in Japanese men Am J Cardiol 86 2000 682 684
25. J. Karhukorpi, Y. Yan, S. Niemela, J. Valtonen, P Koistinen, T Joensuu, P Saikku, and R Karttunen Effect of CD14 promoter polymorphism and H. pylori infection and its clinical outcomes on circulating CD14 Clin Exp Immunol 128 2002 326 332
26. W. Koenig, N. Khuseyinova, M.M. Hoffmann, W. März, M. Fröhlich, and A. Hoffmeister CD14 C (-260)→T polymorphism, plasma levels of the soluble endotoxin receptor CD14, their association with chronic infection and risk of stable coronary artery disease J Am Coll Cardiol 40 2002 34 42
27. R.Y.L. Zee, K. Lindpaintner, B. Struk, C.H. Hennekens, and P.M. Ridker A prospective evaluation of the CD14 C(-260)T gene polymorphism and the risk of myocardial infarction Atherosclerosis 154 2001 699 702
28. K.K. Kidd Associations of disease with genetic markers: déjà vu all over again Am J Med Genet (Neuropsych Genet) 48 1993 71 73
29. M. Behari, A.K. Srivastava, R.R. Das, and R.M. Pandey Risk factors of Parkinson's disease in Indian patients J Neurol Sci 190 2001 49 55
30. R. Maywuz, J. Denaro, N. Hemenegildo, K. Marder, M.X. Tang, and L.J. Cote A population-based investigation of Parkinson's disease with and without dementia Relationship to age and gender. Arch Neurol l49 1992 49 57
31. G.F. Wooten, L.J. Currie, V.E. Bovbjerg, J.K. Lee, and J. Patrie Are men at greater risk for Parkinson's disease than women? J Neurol Neurosurg Psychiatry 75 2004 637 639
32. D.E. Dluzen, and J.L. McDermott Gender differences in neurotoxicity of the nigrostriatal dopaminergic system: implications for Parkinson's disease J Gend Spec Med 3 2000 36 42
33. K.A. Disshon, and D.E. Dluzen Estrogen as a neuromodulator of MPTP-induced neurotoxicity: effects upon striatal dopamine release Brain Res 746 1997 9 16
34. M.W. Horstink, E. Strijks, and D.E. Dluzen Estrogen and Parkinson's disease Adv Neurol 91 2003 107 114
35. L.M. Shulman Is there a connection between estrogen and Parkinson's disease? Parkinsonism Rel Disord 8 2002 289 295
36. A. Czlonkowska, A. Ciesielska, G. Gromadzka, and I. Kurkowska-Jastrzebska Estrogen and cytokines production - the possible cause of gender difference in neurological disease Curr Pharm Design 11 2005 1017 1130